XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Convertible Preferred Stock and Stockholders' Equity (Deficit) - Summary of Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Number of Outstanding Options, Beginning balance | shares 5,654,663  
Number of Outstanding Options, Granted | shares 2,039,340  
Number of Outstanding Options, Exercised | shares (7,405)  
Number of Outstanding Options, Forfeited or cancelled | shares (137,628)  
Number of Outstanding Options, Ending balance | shares 7,548,970 5,654,663
Number of Outstanding Options, Vested and expected to vest | shares 7,548,970  
Number of Outstanding Options, Exercisable | shares 5,007,697  
Weighted- Average Exercise Price, Beginning balance | $ / shares $ 9.65  
Weighted- Average Exercise Price, Granted | $ / shares 17.67  
Weighted- Average Exercise Price, Exercised | $ / shares 0.17  
Weighted- Average Exercise Price, Forfeited or cancelled | $ / shares 13.46  
Weighted- Average Exercise Price, Ending balance | $ / shares 11.76 $ 9.65
Weighted- Average Exercise Price, Vested and expected to vest | $ / shares 11.76  
Weighted- Average Exercise Price, Exercisable | $ / shares $ 7.45  
Weighted- Average Remaining Contractual Term 8 years 11 months 15 days 9 years 2 months 19 days
Weighted- Average Remaining Contractual Term, Vested and expected to vest 8 years 11 months 15 days  
Weighted- Average Remaining Contractual Term, Exercisable 8 years 8 months 4 days  
Aggregate Intrinsic Value | $ $ 25,328 $ 62,954
Aggregate Intrinsic Value, Vested and expected to vest | $ 25,328  
Aggregate Intrinsic Value, Exercisable | $ $ 24,457